Decision 2020/960 - Adoption of the 2020-2023 high flux reactor supplementary research programme at Petten to be implemented by the Joint Research Centre for Euratom - Main contents
Please note
This page contains a limited version of this dossier in the EU Monitor.
Contents
official title
Council Decision (Euratom) 2020/960 of 29 June 2020 on the adoption of the 2020-2023 high flux reactor supplementary research programme at Petten to be implemented by the Joint Research Centre for the European Atomic Energy Community| Legal instrument | Decision |
|---|---|
| Number legal act | Decision 2020/960 |
| Original proposal | COM(2020)108  |
| CELEX number i | 32020D0960 |
| Document | 29-06-2020; Date of adoption |
|---|---|
| Publication in Official Journal | 03-07-2020; OJ L 211 p. 14-17 |
| Effect | 01-01-2020; Application See Art 6 04-07-2020; Entry into force Date pub. +1 See Art 6 |
| End of validity | 31-12-2023; End of season See Art. 1 |
| Notification | 01-07-2020 |
3.7.2020 |
EN |
Official Journal of the European Union |
L 211/14 |
COUNCIL DECISION (Euratom) 2020/960
of 29 June 2020
on the adoption of the 2020-2023 high flux reactor supplementary research programme at Petten to be implemented by the Joint Research Centre for the European Atomic Energy Community
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Atomic Energy Community, and in particular Article 7 thereof,
Having regard to the proposal from the European Commission,
After consulting the Scientific and Technical Committee,
Whereas:
(1) |
The high flux reactor at Petten (‘HFR’) has been an important resource for Community research on materials sciences and testing, on nuclear medicine and on nuclear reactor safety. |
(2) |
The operation of the HFR has been supported by a series of supplementary research programmes. The last supplementary research programme, which was established under Council Decision (Euratom) 2017/956 (1) for a four year term, expired on 31 December 2019. |
(3) |
Considering its continued importance as an irreplaceable infrastructure for Community research in the fields of improvement of nuclear reactors safety, health (including the development of medical isotopes for medical research), nuclear fusion, fundamental research, training, and waste management (including the possibility to study the safety behaviour of nuclear fuels for reactor systems of interest to Europe), the HFR should continue to be supported by a supplementary research programme until the end of 2023. |
(4) |
Due to their special interest in the irradiation capabilities of the HFR, the NRG: Nuclear Research and consultancy Group V.O.F (‘NRG’) and the Commissariat à l’énergie atomique et aux énergies alternatives (‘CEA’), as implementing agents for the Netherlands and France, respectively, have agreed to finance the entire 2020-2023 HFR supplementary research programme through contributions to the general budget of the Union by way of assigned revenue. |
(5) |
Those contributions should finance the operation of the HFR in order to support a research programme and the regular operation and maintenance of the HFR. An official notification of definitive shutdown by the operator NRG to the Dutch national regulatory authority prior to the declaration of a safe conservation state should result in the suspension of payments that remain to be effected and in the suspension of any calls for funds by the Commission. |
(6) |
In order to ensure continuity between the supplementary research programmes and the smooth operation of the 2020-2023 HFR supplementary research programme, this Decision should apply from 1 January 2020. Part of the contributions under the 2020-2023 HFR supplementary research programme should be permitted to cover expenditure made during the year 2020. |
(7) |
The Board of Governors of the Joint Research Centre provided its prior opinion (2) pursuant to Article 4(2) of Commission Decision 96/282/Euratom (3), |
HAS ADOPTED THIS DECISION:
Article 1
The supplementary research programme on the operation of the High Flux Reactor at Petten (‘HFR’) (‘the programme’), the objectives of which are set out in Annex I, shall be adopted for a period of four years, starting on 1 January 2020.
Article 2
The costs for the execution of the programme, estimated at EUR 27 854 000, shall be financed entirely out of contributions from the Netherlands and France, through the NRG and CEA, respectively. The breakdown of this amount is set out in Annex II. This contribution shall be considered as assigned revenue in accordance with Article 21(2), point (a)(i), of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council (4).
Article 3
-
1.The Commission shall be in charge of the...
More
This text has been adopted from EUR-Lex.
This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.
This page is also available in a full version containing the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and the related cases of the European Court of Justice.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.